ARTAL GROUP S.A. – Alnylam Pharmaceuticals, Inc. Transaction History
ARTAL GROUP S.A. portfolio value:
$0
portfolio value
ARTAL GROUP S.A. quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -600K shares | -87.51M | $200.16 | 0 |
| Q2 2022 | share | Decrease | -7.69% | -50K shares | -18.62M | $145.85 | 600K |
| Q1 2022 | share | 0.00% | 0 shares | -4.08M | $163.29 | 650K | |
| Q4 2021 | share | Decrease | -7.14% | -50K shares | -21.94M | $171.03 | 650K |
| Q3 2021 | share | Decrease | -6.67% | -50K shares | 5.02M | $188.81 | 700K |
| Q2 2021 | share | 0.00% | 0 shares | 21.24M | $169.52 | 750K | |
| Q1 2021 | call | Decrease | -100.00% | -200K shares | -25.99M | $141.19 | 0 |
| Q1 2021 | share | Decrease | -6.25% | -50K shares | 1.91M | $141.19 | 750K |
| Q4 2020 | call | Increase | 0.00% | 200K shares | 25.99M | $129.97 | 200K |
| Q4 2020 | share | 0.00% | 0 shares | -12.50M | $129.97 | 800K | |
| Q3 2020 | share | Decrease | -11.11% | -100K shares | -16.81M | $145.6 | 800K |
| Q3 2020 | call | Decrease | -100.00% | -100K shares | -14.81M | $145.6 | 0 |
| Q2 2020 | call | Increase | 0.00% | 100K shares | 14.81M | $148.11 | 100K |
| Q2 2020 | share | Decrease | -18.18% | -200K shares | 13.56M | $148.11 | 900K |
| Q1 2020 | share | Increase | +10.00% | 100K shares | 4.56M | $108.85 | 1.1M |
| Q4 2019 | share | Increase | +42.86% | 300K shares | 58.87M | $115.17 | 1M |
| Q3 2019 | call | Decrease | -100.00% | -150K shares | -10.88M | $80.42 | 0 |
| Q3 2019 | share | Increase | +75.00% | 300K shares | 27.27M | $80.42 | 700K |
| Q2 2019 | call | Increase | 0.00% | 150K shares | 10.88M | $72.56 | 150K |
| Q2 2019 | share | Decrease | -11.11% | -50K shares | -13.02M | $72.56 | 400K |
| Q1 2019 | share | Decrease | -10.00% | -50K shares | 5.59M | $93.45 | 450K |
| Q1 2019 | call | Decrease | -100.00% | -300K shares | -21.87M | $93.45 | 0 |
| Q4 2018 | share | Decrease | -16.67% | -100K shares | -16.05M | $72.91 | 500K |
| Q4 2018 | call | Increase | +200.00% | 200K shares | 13.12M | $72.91 | 300K |
| Q3 2018 | share | Decrease | -7.69% | -50K shares | -11.50M | $87.52 | 600K |
| Q3 2018 | call | 0.00% | 0 shares | -1.09M | $87.52 | 100K | |
| Q2 2018 | share | Increase | +8.33% | 50K shares | -7.44M | $98.49 | 650K |
| Q2 2018 | call | Increase | 0.00% | 100K shares | 9.84M | $98.49 | 100K |
| Q1 2018 | call | Decrease | -100.00% | -200K shares | -25.41M | $119.1 | 0 |
| Q1 2018 | share | Increase | +33.33% | 150K shares | 14.28M | $119.1 | 600K |
| Q4 2017 | share | Increase | +80.00% | 200K shares | 27.8M | $127.05 | 450K |
| Q4 2017 | call | Increase | 0.00% | 200K shares | 25.41M | $127.05 | 200K |
| Q3 2017 | share | Decrease | -9.09% | -25K shares | 7.43M | $117.49 | 250K |
| Q2 2017 | share | Decrease | -8.33% | -25K shares | 6.55M | $79.76 | 275K |
| Q1 2017 | share | Decrease | -40.00% | -200K shares | -3.34M | $51.25 | 300K |
| Q1 2017 | call | Decrease | -100.00% | -200K shares | -7.48M | $51.25 | 0 |
| Q4 2016 | share | Decrease | -16.67% | -100K shares | -21.94M | $37.44 | 500K |
| Q4 2016 | call | Increase | +100.00% | 100K shares | 710K | $37.44 | 200K |
| Q3 2016 | share | Decrease | -15.49% | -110K shares | 1.27M | $67.78 | 600K |
| Q3 2016 | call | Decrease | -66.67% | -200K shares | -9.86M | $67.78 | 100K |
| Q2 2016 | share | Increase | +18.33% | 110K shares | 1.73M | $55.49 | 710K |
| Q2 2016 | call | Increase | +100.00% | 150K shares | 7.23M | $55.49 | 300K |
| Q1 2016 | share | Increase | +26.32% | 125K shares | -7.05M | $62.77 | 600K |
| Q1 2016 | call | Increase | 0.00% | 150K shares | 9.41M | $62.77 | 150K |